Black Rock Inc. Bio Xcel Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,328,061 shares of BTAI stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,328,061

Previous 1,374,209 3.36%

Holding current value

$1.7 Million

Previous $4.05 Million 7.6%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.95 - $4.04 $89,988 - $186,437	-46,148 Reduced 3.36%	1,328,061 $3.75 Million
Q4 2023 Feb 13, 2024	BUY	$2.32 - $5.51 $177,480 - $421,515	76,500 Added 5.9%	1,374,209 $4.05 Million
Q3 2023 Nov 13, 2023	SELL	$2.49 - $11.85 $227,884 - $1.08 Million	-91,520 Reduced 6.59%	1,297,709 $3.28 Million
Q2 2023 Aug 11, 2023	BUY	$6.39 - $28.58 $118,476 - $529,901	18,541 Added 1.35%	1,389,229 $9.25 Million
Q1 2023 May 12, 2023	SELL	$17.7 - $33.24 $1.63 Million - $3.07 Million	-92,234 Reduced 6.3%	1,370,688 $25.6 Million

Q4 2022 Feb 13, 2023	SELL	$10.25 - $22.43 $4,612 - $10,093	-450 Reduced 0.03%	1,462,922 $31.4 Million
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $447,879 - $716,047	40,025 Added 2.81%	1,463,372 $17.3 Million
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $1.29 Million - $3.07 Million	142,368 Added 11.11%	1,423,347 $18.8 Million
Q1 2022 May 12, 2022	SELL	$15.0 - $22.83 $130,125 - $198,050	-8,675 Reduced 0.67%	1,280,979 $26.8 Million
Q4 2021 Feb 10, 2022	BUY	$20.12 - $35.09 $1.47 Million - $2.56 Million	72,917 Added 5.99%	1,289,654 $26.2 Million
Q3 2021 Nov 09, 2021	BUY	$23.84 - $32.03 $2.01 Million - $2.7 Million	84,335 Added 7.45%	1,216,737 $36.9 Million
Q2 2021 Aug 11, 2021	BUY	$29.06 - $38.83 $32.9 Million - $44 Million	1,132,402 New	1,132,402 $32.9 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

6.6M

Call Options Held

85K

Put Options Held

221K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $35.9M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account